EichorEICHOR
Study identifier: NCT07686484 Synced from ClinicalTrials.gov · August 11, 2026
● Study status: Recruiting

A Trial of HRS-3095 in Healthy Volunteers

Condition: Chronic Spontaneous Urticaria  ·  Sponsor: Atridia Pty Ltd.

PhaseEARLY_Phase 1
Planned participants36
Who can joinAll sexes, 18 Years to 55 Years
Healthy volunteersYesCheck eligibility criteria ↓
WhereBayswater, Victoria, Australia

Interested? Contact the study team ↓

For sponsors, CROs & site teams
Professional view of this study — listed sites, countries and recruiting context from the public registry. Everything below is written for patients and caregivers.See where this study is running →

About this study

The purpose of this study is to assess safety, PK, Pharmacodynamic profile of a single dose of HRS-3095 in healthy participants

This description comes directly from the study's public registry record.

Talk to the study team

Kathy You  ·  +61 02 9299 0433  ·  kathyyou@atridia.com

Eimy Minowa  ·  +61 432223162  ·  eimy.minowa@atridia.com

There is no obligation to join — the study team can answer your questions about taking part.

Always discuss trial participation with your own doctor first.

Full eligibility criteria (exactly as the study team wrote them)

Main inclusion criteria 1. Healthy white participants. 2. Male or female aged between 18 years and 55 years (inclusive) 3. Ability to understand the trial procedures and possible adverse events, volunteer to participate in the trial, and provide written informed consent, be able to comply with all the requirements, and able to complete the study. 4. Women with body weight ≥ 45.0 kg, men with body weight ≥ 50.0 kg, body mass index (BMI) between 19.0 and 30.0 kg/m2 (inclusive) at screening. 5. Men and WOCBP must agree to take highly effective contraceptive methods Main exclusion Criteria 1. History or evidence of clinically significant disorders. 2. Individuals with a history of drug allergies, specific allergies, or known history or suspected of being allergic to the study drug or same class drug or any component of it. 3. Receipt of medical devices or another investigational drug within 3 months or 5 half-lives, whichever is longer prior to screening. 4. History of excessive smoking in the past 1 month prior to screening 5. History of illicit or prescription drug abuse or addiction within 1 year of screening, or positive urine drug screen at baseline. 6. Any other circumstances (e.g., not suitable for venous access) or laboratory abnormality that, in the investigator's judgment, may increase the risk to the participant, or be associated with the participant's participation in and completion of the study or could preclude the evaluation of the participant's response. NOTE: Other protocol defined Inclusion/Exclusion criteria may apply

Reproduced word-for-word from the public registry record — the study team can answer questions about it.

Locations (1)

Veritus ResearchBayswater, Victoria, AustraliaRecruiting

More studies in these areas

This study lists sites in the areas below. Each link shows other recruiting studies near that city, from the public registry record.

Bayswater

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Look up another condition
Look up another city
Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →